Lipocine (LPCN) stock price, revenue, and financials

Lipocine market cap is $32.1 m, and annual revenue was $428.03 k in FY 2018

$32.1 M

LPCN Mkt cap, 10-Jun-2019

$428 K

Lipocine Revenue FY, 2018
Lipocine Net income (FY, 2018)-11.7 M
Lipocine EBIT (FY, 2018)-11.3 M
Lipocine Cash, 31-Dec-20188.1 M

Lipocine Income Statement

Annual

USDFY, 2013Y, 2013FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

428.0k

R&D expense

5.1m12.6m8.1m11.0m6.5m

General and administrative expense

3.6m5.8m10.4m10.2m5.3m

Operating expense total

10.7m18.4m19.2m21.2m11.8m

EBIT

(10.7m)(10.7m)(18.4m)(19.2m)(21.2m)(11.3m)

EBIT margin, %

(2646%)

Pre tax profit

(10.6m)(18.2m)(19.0m)(21.0m)(11.7m)

Income tax expense

55.0k55.0k(200.0)(752.0)(700.0)(700.0)

Net Income

(10.6m)(10.6m)(18.2m)(19.0m)(21.0m)(11.7m)

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Revenue

428.0k428.0k

R&D expense

1.6m3.4m6.0m3.2m1.9m3.2m4.7m2.7m2.6m1.5m3.1m4.1m1.4m1.5m

General and administrative expense

1.2m1.9m1.0m871.8k1.1m1.1m1.7m4.4m3.2m1.4m1.8m2.0m1.7m1.7m

Operating expense total

2.8m5.3m7.0m4.1m3.0m4.3m6.4m7.1m5.8m3.3m4.9m6.1m4.8m3.1m3.2m

EBIT

(3.5m)(5.3m)(7.0m)(4.1m)(3.0m)(4.3m)(6.4m)(7.1m)(5.8m)(3.3m)(4.9m)(6.1m)(4.8m)(2.6m)(3.2m)

EBIT margin, %

(616%)(739%)

Interest expense

192.5k211.5k

Pre tax profit

(3.5m)(5.3m)(7.0m)(4.1m)(4.2m)(6.4m)(7.0m)(5.8m)(4.9m)(6.1m)(2.7m)(3.3m)

Income tax expense

55.3k(200.0)(700.0)(700.0)(700.0)(700.0)

Net Income

(3.5m)(5.3m)(7.0m)(4.1m)(3.0m)(4.2m)(6.4m)(7.0m)(5.8m)(3.2m)(4.9m)(6.1m)(4.7m)(2.7m)(3.3m)

Lipocine Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

45.3m27.7m20.0m5.6m3.2m8.1m

Accounts Receivable

Inventories

Current Assets

46.0m27.9m44.9m27.2m25.2m20.8m

PP&E

28.8k

Total Assets

46.1m28.0m45.4m27.3m25.3m20.9m

Accounts Payable

1.0m306.3k507.1k245.9k598.1k671.3k

Short-term debt

Current Liabilities

1.3m1.6m3.4m1.3m6.3m4.5m

Long-term debt

Total Debt

Total Liabilities

1.3m3.4m1.3m6.3m11.4m

Additional Paid-in Capital

92.7m94.6m128.5m131.5m145.4m147.5m

Retained Earnings

(47.9m)(68.2m)(86.4m)(105.4m)(126.4m)(138.1m)

Total Equity

26.4m42.0m26.0m19.0m9.4m

Financial Leverage

1.1 x1.1 x1.1 x1.3 x2.2 x

Lipocine Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(10.6m)(20.4m)(18.2m)(19.0m)(21.0m)(11.7m)

Depreciation and Amortization

21.8k14.6k26.7k32.0k28.4k18.6k

Accounts Receivable

Inventories

Accounts Payable

668.8k(449.6k)200.8k(261.2k)352.2k73.2k

Purchases of PP&E

(1.2k)(59.6k)(28.7k)(59.6k)

Cash From Investing Activities

(1.2k)(25.0m)

Cash From Financing Activities

48.5m(255.1k)11.2m10.7m

Interest Paid

533.5k

Income Taxes Paid

700.0700.0

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Net Income

(6.2m)(5.3m)(12.2m)(16.3m)(3.0m)(7.2m)(13.6m)(7.0m)(12.8m)(3.2m)(4.9m)(11.0m)(4.7m)(2.7m)(6.0m)

Depreciation and Amortization

15.7k3.0k6.1k9.4k8.7k19.6k6.7k15.5k7.1k14.2k5.3k9.7k

Accounts Payable

1.1m(254.0k)(385.2k)(627.9k)379.5k30.1k150.6k570.1k482.0k865.0k607.6k867.9k803.8k(209.7k)(191.5k)

Purchases of PP&E

(1.2k)(1.9k)(1.9k)(21.3k)(14.8k)(28.7k)(39.2k)(59.6k)

Cash From Investing Activities

(1.2k)(1.9k)(33.0)(24.0m)

Cash From Financing Activities

35.9m16.1k34.2k34.2k3.1m8.8m10.0m10.0m

Interest Paid

274.0k

Income Taxes Paid

700.0700.0700.0700.0700.0

Lipocine Ratios

USDY, 2018

Revenue/Employee

42.8k

Financial Leverage

2.2 x